Cargando…

The Role of Metabolic Syndrome in Endometrial Cancer: A Review

Endometrial cancer is one of the most common cancers of the female reproductive system. Although surgery, radiotherapy, chemotherapy, and hormone therapy can significantly improve the survival of patients, the treatment of patients with very early lesions and a strong desire to retain reproductive f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Xiao, Wang, Jianliu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6694738/ https://www.ncbi.nlm.nih.gov/pubmed/31440472 http://dx.doi.org/10.3389/fonc.2019.00744

Ejemplares similares

Insulin Resistance and Metabolic Syndrome Increase the Risk of Relapse For Fertility Preserving Treatment in Atypical Endometrial Hyperplasia and Early Endometrial Cancer Patients
por: Li, Xingchen, et al.
Publicado: (2021)

Identification of a Metabolism-Related Signature for the Prediction of Survival in Endometrial Cancer Patients
por: Fan, Yuan, et al.
Publicado: (2021)

Sentinel Lymph Node Mapping in Endometrial Cancer: A Comprehensive Review
por: Zhai, Lirong, et al.
Publicado: (2021)

Mechanical Stimulus-Related Risk Signature Plays a Key Role in the Prognostic Nomogram For Endometrial Cancer
por: Xu, Xin, et al.
Publicado: (2021)

Role of the Glyoxalase System in Breast Cancer and Gynecological Cancer-Implications for Therapeutic Intervention: a Review
por: Wang, Jingyuan, et al.
Publicado: (2022)

Tumor Molecular Features Predict Endometrial Cancer Patients’ Survival After Open or Minimally Invasive Surgeries
por: Dai, Yibo, et al.
Publicado: (2021)

Effects of Metabolic Syndrome and Its Components on the Prognosis of Endometrial Cancer
por: Yang, Xiao, et al.
Publicado: (2021)

Maintenance Therapy Can Improve the Oncologic Prognosis and Obstetrical Outcome of Patients With Atypical Endometrial Hyperplasia and Endometrial Cancer After Fertility-Preserving Treatment: A Multicenter Retrospective Study
por: He, Yijiao, et al.
Publicado: (2021)

Reconstruction of Immune Microenvironment and Signaling Pathways in Endometrioid Endometrial Adenocarcinoma During Formation of Lymphovascular Space Involvement and Lymph Node Metastasis
por: Cheng, Yuan, et al.
Publicado: (2020)

Glutamine and amino acid metabolism as a prognostic signature and therapeutic target in endometrial cancer
por: Zhai, Lirong, et al.
Publicado: (2023)

An Externally Validated Nomogram for Predicting Lymph Node Metastasis of Presumed Stage I and II Endometrial Cancer
por: Dong, Yangyang, et al.
Publicado: (2019)

Development and Validation of a Nomogram Based on Metabolic Risk Score for Assessing Lymphovascular Space Invasion in Patients with Endometrial Cancer
por: Wang, Jingyuan, et al.
Publicado: (2022)

Multi-Omic Profiling of Multi-Biosamples Reveals the Role of Amino Acid and Nucleotide Metabolism in Endometrial Cancer
por: Yi, Runqiu, et al.
Publicado: (2022)

Serum calcium is a novel parameter to assess metabolic syndrome in endometrial carcinoma
por: Lin, Yanying, et al.
Publicado: (2018)

An Efficacious Endometrial Sampler for Screening Endometrial Cancer
por: Han, Lu, et al.
Publicado: (2019)

Metabolic syndrome is an independent risk factor for time to complete remission of fertility-sparing treatment in atypical endometrial hyperplasia and early endometrial carcinoma patients
por: Ding, Yingqiao, et al.
Publicado: (2022)

Metabolic disorders sensitise endometrial carcinoma through endoplasmic reticulum stress
por: Zhou, Jingyi, et al.
Publicado: (2022)

Relationship between Hypothyroidism and Endometrial Cancer
por: Wang, Yiqin, et al.
Publicado: (2019)

Development and validation of a prognostic model based on metabolic risk score to predict overall survival of endometrial cancer in Chinese patients
por: Li, Xingchen, et al.
Publicado: (2023)

Role of HIF-1α/ERRα in Enhancing Cancer Cell Metabolism and Promoting Resistance of Endometrial Cancer Cells to Pyroptosis
por: Su, Pingping, et al.
Publicado: (2022)

Fertility-Sparing Treatment for Endometrial Cancer or Atypical Endometrial Hyperplasia Patients With Obesity
por: Chen, Junyu, et al.
Publicado: (2022)

The Ratio of Neutrophil to Lymphocyte is a Predictor in Endometrial Cancer
por: Dong, Yangyang, et al.
Publicado: (2019)

Metabolic Syndrome as a Risk Factor of Endometrial Cancer: A Nationwide Population-Based Cohort Study of 2.8 Million Women in South Korea
por: Jo, HyunA, et al.
Publicado: (2022)

Additional Value of PET/CT-Based Radiomics to Metabolic Parameters in Diagnosing Lynch Syndrome and Predicting PD1 Expression in Endometrial Carcinoma
por: Wang, Xinghao, et al.
Publicado: (2021)

The roles and clinical applications of interleukins in endometrial carcinoma
por: Zang, Yuqin, et al.
Publicado: (2022)

Anti-estrogen Treatment in Endometrial Cancer: A Systematic Review
por: van Weelden, Willem Jan, et al.
Publicado: (2019)

Importance of the endometrial immune environment in endometrial cancer and associated therapies
por: van der Woude, Hannah, et al.
Publicado: (2022)

The Role of Aberrant Metabolism in Cancer: Insights Into the Interplay Between Cell Metabolic Reprogramming, Metabolic Syndrome, and Cancer
por: Yu, Yina, et al.
Publicado: (2020)

Prognostic and Clinicopathological Role of PD-L1 in Endometrial Cancer: A Meta-Analysis
por: Lu, Ling, et al.
Publicado: (2020)

The role of tumor-associated macrophages in the progression, prognosis and treatment of endometrial cancer
por: Sun, Yihan, et al.
Publicado: (2023)

Assessing the Role of Selenium in Endometrial Cancer Risk: A Mendelian Randomization Study
por: Kho, Pik Fang, et al.
Publicado: (2019)

Management of Recurrent Endometrial Cancer or Atypical Endometrial Hyperplasia Patients After Primary Fertility-Sparing Therapy
por: Chen, Junyu, et al.
Publicado: (2021)

The impact of adipose tissue distribution on endometrial cancer: a systematic review
por: van den Bosch, Anouk A. S., et al.
Publicado: (2023)

Endometrial Cytology as a Method to Improve the Accuracy of Diagnosis of Endometrial Cancer: Case Report and Meta-Analysis
por: Wang, Qing, et al.
Publicado: (2019)

Telomerase and Telomeres in Endometrial Cancer
por: Alnafakh, Rafah A. A., et al.
Publicado: (2019)

How Immunotherapy Modified the Therapeutic Scenario of Endometrial Cancer: A Systematic Review
por: Maiorano, Brigida Anna, et al.
Publicado: (2022)

Different multiparametric MRI-based radiomics models for differentiating stage IA endometrial cancer from benign endometrial lesions: A multicenter study
por: Bi, Qiu, et al.
Publicado: (2022)

Noninvasive Predictor for Premalignant and Cancerous Lesions in Endometrial Polyps Diagnosed by Ultrasound
por: Xu, Jianying, et al.
Publicado: (2022)

Chlorpromazine Sensitizes Progestin-Resistant Endometrial Cancer Cells to MPA by Upregulating PRB
por: Cui, Yunxia, et al.
Publicado: (2021)

Long‐term risk of endometrial cancer following postmenopausal bleeding and reassuring endometrial biopsy
por: Visser, Nicole C.M., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_b8r7davg8gfk20msp0u944musv